ResMed Inc. (NYSE: RMD) and Fisher & Paykel Healthcare Corporation Limited (NZSE: FPH, ASX: FPH) announced that they have settled the patent infringement lawsuit ResMed filed against Fisher & Paykel over Fisher & Paykel’s Aclaim mask products, used in the treatment of sleep-disordered breathing. ResMed will dismiss the lawsuit, which was filed in US District Court in San Diego, California. Both parties are pleased to have settled the dispute.
Fisher & Paykel will be introducing a new design of its Aclaim mask by August 1, 2003, and ResMed will not assert intellectual property claims against the new mask. In addition, Fisher & Paykel will continue to sell its existing Aclaim masks under a license from ResMed until it introduces the new version. The remaining terms and conditions of the settlement are confidential.
ResMed is a leading developer, manufacturer, and marketer of medical equipment for the diagnosis, treatment, and management of sleep-disordered breathing, selling a comprehensive range of products in over 60 countries.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of heated humidification products and systems for use in respiratory care and the treatment of obstructive sleep apnea. It also offers an innovative range of patient warming devices and neonatal care products. Its products are sold in over 90 countries worldwide.
Further information can be obtained by contacting:
This release includes forward-looking statements concerning the parties’ agreement. Words such as “expects,” “believes,” “plans,” “will” and similar expressions are intended to identify forward- looking statements. These statements are based on assumptions about many important factors, including future sales of products and other factors identified in each company’s filings with the Securities and Exchange Commission, including its most recent Form 10-K and Form 10-Q. Actual results may differ materially. The companies do not undertake to update their forward-looking statements.
Resmed and Fisher & Paykel Healthcare settle patent dispute
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional.
I am a health professional. P>
Remember my choice